Seroatlas · Human Serome Atlas

TAT

Tyrosine aminotransferase

Also known as: ATTY_HUMAN

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
P17735
Gene
TAT
Ensembl
ENSG00000198650
Chromosome
16
Canonical length
454 aa
Protein class
Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins
Quaternary structure
Homodimer

OverviewNCBI Gene

This nuclear gene encodes a mitochondrial protein tyrosine aminotransferase which is present in the liver and catalyzes the conversion of L-tyrosine into p-hydroxyphenylpyruvate. Mutations in this gene cause tyrosinemia (type II, Richner-Hanhart syndrome), a disorder accompanied by major skin and corneal lesions, with possible cognitive disability. A regulator gene for tyrosine aminotransferase is X-linked. [provided by RefSeq, Jul 2008]

Canonical amino-acid sequenceUniProt

454 residues, UniProt reviewed canonical sequence.

>P17735|TAT
     1  MDPYMIQMSS KGNLPSILDV HVNVGGRSSV PGKMKGRKAR WSVRPSDMAK KTFNPIRAIV
    61  DNMKVKPNPN KTMISLSIGD PTVFGNLPTD PEVTQAMKDA LDSGKYNGYA PSIGFLSSRE
   121  EIASYYHCPE APLEAKDVIL TSGCSQAIDL CLAVLANPGQ NILVPRPGFS LYKTLAESMG
   181  IEVKLYNLLP EKSWEIDLKQ LEYLIDEKTA CLIVNNPSNP CGSVFSKRHL QKILAVAARQ
   241  CVPILADEIY GDMVFSDCKY EPLATLSTDV PILSCGGLAK RWLVPGWRLG WILIHDRRDI
   301  FGNEIRDGLV KLSQRILGPC TIVQGALKSI LCRTPGEFYH NTLSFLKSNA DLCYGALAAI
   361  PGLRPVRPSG AMYLMVGIEM EHFPEFENDV EFTERLVAEQ SVHCLPATCF EYPNFIRVVI
   421  TVPEVMMLEA CSRIQEFCEQ HYHCAEGSQE ECDK

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against TAT can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Intracellular
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.28
Highest tissue expression
1,188 nTPM

Expression across tissuesHPA

Tissue

  • liver: 1,188 nTPM
  • breast: 55 nTPM
  • testis: 1.7 nTPM
  • gallbladder: 0.7 nTPM
  • spleen: 0.7 nTPM
  • retina: 0.6 nTPM

Single-cell type

  • hepatocytes: 5,253 nCPM
  • breast hormone-responsive cells: 171 nCPM
  • cholangiocytes: 64 nCPM
  • hepatic stellate cells: 19 nCPM
  • kupffer cells: 13 nCPM
  • enterocytes: 7 nCPM

Immune cell

  • plasmacytoid DC: 0.6 nTPM
  • naive B-cell: 0.4 nTPM
  • basophil: 0.3 nTPM
  • memory B-cell: 0.2 nTPM
  • neutrophil: 0.2 nTPM
  • memory CD4 T-cell: 0.1 nTPM

Brain region

  • white matter: 1.5 nTPM
  • cerebral cortex: 1.3 nTPM
  • basal ganglia: 1.2 nTPM
  • hypothalamus: 1.2 nTPM
  • medulla oblongata: 1.2 nTPM
  • pons: 1.2 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about TAT.

Disease | AllUniProt

Conditions TAT is implicated in, by any mechanism.

Disease | GeneticClinVar

67 pathogenic / likely-pathogenic of 474 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.61
gnomAD pLI
0.01
gnomAD missense Z
0.76
DepMap mean gene effect
0.04
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 2% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of TAT in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads TAT as an antibody target. Whether an autoantibody or antibody against TAT could matter depends on whether native TAT is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

TAT is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label TAT as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/TAT. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...